An inexpensive sulfur compound with an unusually clean safety record. Its best-studied use is easing pain and stiffness in worn knee joints, though larger reviews disagree on how much it helps. Weaker signals for exercise soreness, allergy symptoms, and skin. Longevity benefits remain plausible but unproven. Low-cost, well-tolerated, low-risk. (Full Review)

Protocol

Dose

3–6 g/day

up to 3–6 g/day for osteoarthritis; 1.5–3 g/day for general or recovery use

Timing

Morning or midday

preferred over evening to avoid occasional sleep disturbance

Split dosing

2–3 doses with meals

for doses above ~2 g/day; improves gastrointestinal tolerability

Time to effect

Joint comfort

6–12 weeks

most trials assess at 6–12 weeks; a fair personal trial runs at least 8–12 weeks

Allergy symptoms

1–3 weeks

upper- and total-respiratory symptoms in an uncontrolled trial

Benefits

Medium: Knee osteoarthritis pain & physical function

Low: Exercise-induced muscle & joint soreness; oxidative stress & antioxidant capacity; seasonal allergic rhinitis symptoms

Speculative: Skin, hair & nail quality; HDL cholesterol & cardiometabolic markers; systemic inflammation & healthy aging

Contraindications

Pregnancy and breastfeeding

Known MSM hypersensitivity

Therapeutic anticoagulation (unstable INR, recent major bleeding)

Key Interactions

Anticoagulants and antiplatelet drugs (warfarin, apixaban, clopidogrel)

OTC blood thinners (aspirin, ibuprofen, naproxen)

Antiplatelet supplements (high-dose fish oil, vitamin E, ginkgo, garlic)

Discontinue before surgery

Risk & Side Effects

High: Gastrointestinal discomfort

Medium: Mild neurological & sleep effects

Low: Skin reactions & itching

Speculative: Theoretical bleeding risk with blood thinners; unknown safety in pregnancy & lactation

Monitoring

Marker	Target	Why
hs-CRP	< 1.0 mg/L (ideally < 0.5)	Systemic inflammation, the pathway MSM is proposed to influence
HDL cholesterol	> 60 mg/dL	Follows the exploratory cardiometabolic (HDL-raising) signal
ALT & AST	ALT < 25 U/L (men) / < 20 U/L (women); AST similar	Liver safety check for long-term or high-dose use
Homocysteine	< 7–8 µmol/L	Sulfur amino-acid and methylation status
eGFR / creatinine	eGFR > 90 mL/min/1.73m²	Confirms kidney clearance capacity before higher-dose use

Cadence: Baseline, re-check at ~12 weeks, then every 6–12 months

Qualitative Assessment

Joint comfort and range of motion during daily activities
Morning stiffness duration and severity
Post-exercise muscle soreness and recovery time
Energy levels and general sense of well-being
Skin, hair, and nail quality over months of use
Sleep quality (to confirm MSM is not disrupting it)

MSM for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment